Interferons Inhibit Activation of STAT6 by Interleukin 4 in Human Monocytes by Inducing SOCS-1 Gene Expression
Overview
Affiliations
Interferons (IFNs) inhibit induction by IL-4 of multiple genes in human monocytes. However, the mechanism by which IFNs mediate this inhibition has not been defined. IL-4 activates gene expression by inducing tyrosine phosphorylation, homodimerization, and nuclear translocation of the latent transcription factor, STAT6 (signal transducer and activator of transcription-6). STAT6-responsive elements are characteristically present in the promoters of IL-4-inducible genes. Because STAT6 activation is essential for IL-4-induced gene expression, we examined the ability of type I and type II IFNs to regulate activation of STAT6 by IL-4 in primary human monocytes. Pretreatment of monocytes with IFN-beta or IFN-gamma, but not IL-1, IL-2, macrophage colony-stimulating factor, granulocyte/macrophage colony-stimulating factor, IL-6, or transforming growth factor beta suppressed activation of STAT6 by IL-4. This inhibition was associated with decreased tyrosine phosphorylation and nuclear translocation of STAT6 and was not evident unless the cells were preincubated with IFN for at least 1 hr before IL-4 stimulation. Furthermore, inhibition by IFN could be blocked by cotreatment with actinomycin D and correlated temporally with induction of the JAK/STAT inhibitory gene, SOCS-1. Forced expression of SOCS-1 in a macrophage cell line, RAW264, markedly suppressed trans-activation of an IL-4-inducible reporter as well as IL-6- and IFN-gamma-induced reporter gene activity. These findings demonstrate that IFNs inhibit IL-4-induced activation of STAT6 and STAT6-dependent gene expression, at least in part, by inducing expression of SOCS-1.
Overview of Cytomegalovirus Ocular Diseases: Retinitis, Corneal Endotheliitis, and Iridocyclitis.
Kobayashi R, Hashida N Viruses. 2024; 16(7).
PMID: 39066272 PMC: 11281654. DOI: 10.3390/v16071110.
Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
Kanno H, Matsumoto S, Yoshizumi T, Nakahara K, Kubo A, Murata H Int J Mol Sci. 2023; 24(4).
PMID: 36835292 PMC: 9960776. DOI: 10.3390/ijms24043880.
Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.
Shankar A, McAlees J, Lewkowich I J Allergy Clin Immunol. 2022; 150(2):266-276.
PMID: 35934680 PMC: 9371363. DOI: 10.1016/j.jaci.2022.06.012.
Bao X, Liu X, Liu N, Zhuang S, Yang Q, Ren H Respir Res. 2021; 22(1):194.
PMID: 34217280 PMC: 8255011. DOI: 10.1186/s12931-021-01785-x.
Cordes F, Foell D, Ding J, Varga G, Bettenworth D World J Gastroenterol. 2020; 26(28):4055-4075.
PMID: 32821070 PMC: 7403801. DOI: 10.3748/wjg.v26.i28.4055.